Maximus, Inc. $MMS Shares Purchased by LSV Asset Management

LSV Asset Management lifted its holdings in Maximus, Inc. (NYSE:MMS) by 35.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 163,600 shares of the health services provider’s stock after acquiring an additional 42,900 shares during the quarter. LSV Asset Management’s holdings in Maximus were worth $14,122,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. Dimensional Fund Advisors LP boosted its holdings in Maximus by 2.0% during the third quarter. Dimensional Fund Advisors LP now owns 1,869,573 shares of the health services provider’s stock worth $170,812,000 after buying an additional 36,989 shares in the last quarter. Boston Partners boosted its holdings in Maximus by 47.0% during the third quarter. Boston Partners now owns 966,139 shares of the health services provider’s stock worth $88,236,000 after buying an additional 308,892 shares in the last quarter. Federated Hermes Inc. boosted its holdings in Maximus by 1.3% during the third quarter. Federated Hermes Inc. now owns 688,505 shares of the health services provider’s stock worth $62,909,000 after buying an additional 8,847 shares in the last quarter. UBS Group AG boosted its holdings in Maximus by 76.8% during the fourth quarter. UBS Group AG now owns 610,354 shares of the health services provider’s stock worth $52,686,000 after buying an additional 265,095 shares in the last quarter. Finally, Bank of America Corp DE boosted its holdings in Maximus by 24.6% during the third quarter. Bank of America Corp DE now owns 453,616 shares of the health services provider’s stock worth $41,447,000 after buying an additional 89,693 shares in the last quarter. Institutional investors and hedge funds own 97.21% of the company’s stock.

Analyst Ratings Changes

MMS has been the subject of several research analyst reports. Zacks Research downgraded Maximus from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 27th. Weiss Ratings cut shares of Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research note on Wednesday, May 20th. Finally, Wall Street Zen cut shares of Maximus from a “buy” rating to a “hold” rating in a research note on Monday, February 23rd. Two research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the stock currently has an average rating of “Hold”.

Insider Buying and Selling

In other Maximus news, Director Jan Madsen sold 742 shares of Maximus stock in a transaction dated Tuesday, March 17th. The shares were sold at an average price of $72.25, for a total transaction of $53,609.50. Following the transaction, the director directly owned 20,795 shares of the company’s stock, valued at $1,502,438.75. The trade was a 3.45% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 1.80% of the stock is owned by company insiders.

Maximus Stock Performance

NYSE:MMS opened at $61.09 on Tuesday. The company’s 50-day moving average price is $65.26 and its 200-day moving average price is $77.89. The company has a current ratio of 2.21, a quick ratio of 2.21 and a debt-to-equity ratio of 0.87. The company has a market cap of $3.21 billion, a P/E ratio of 9.15 and a beta of 0.60. Maximus, Inc. has a twelve month low of $56.92 and a twelve month high of $100.00.

Maximus (NYSE:MMS) last posted its quarterly earnings results on Thursday, May 7th. The health services provider reported $2.07 earnings per share for the quarter, topping the consensus estimate of $1.98 by $0.09. Maximus had a net margin of 7.02% and a return on equity of 25.10%. The firm had revenue of $1.31 billion for the quarter, compared to the consensus estimate of $1.32 billion. During the same period last year, the firm posted $2.01 earnings per share. The company’s revenue for the quarter was down 4.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. On average, sell-side analysts forecast that Maximus, Inc. will post 8.4 earnings per share for the current fiscal year.

Maximus Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, June 1st. Shareholders of record on Friday, May 15th will be paid a dividend of $0.33 per share. The ex-dividend date of this dividend is Friday, May 15th. This represents a $1.32 dividend on an annualized basis and a yield of 2.2%. Maximus’s payout ratio is 19.76%.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.